An experimental model of retrovirus gene therapy for malignant brain tumors.
about
Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.Gene therapy for diseases of the nervous system.Genetically engineered HSV in the treatment of glioma: a review.Oncolytic viruses as novel anticancer agents: turning one scourge against another.Current status of viral gene therapy for brain tumours.Combination gene therapy for liver metastasis of colon carcinoma in vivoComparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma.Gene therapy and targeted toxins for glioma.The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumorsGelsolin as therapeutic target in Alzheimer's disease.Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.Generation of high-titer retroviral vector-producing macrophages as vehicles for in vivo gene transfer.Gene therapy for cerebrovascular disease.Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.Therapeutic efficacy of the thymidine kinase/ganciclovir system on large experimental gliomas: a nuclear magnetic resonance imaging study.Applications of gene therapy to the CNS.Gene therapy for neurologic disease: benchtop discoveries to bedside applications. 1. The bench.Herpes simplex virus type 1/adeno-associated virus hybrid vectors.Replicative retroviral vectors for cancer gene therapy.Interaction of the recombinant herpes simplex virus type 1 thymidine kinase with thymidine and aciclovir: a kinetic study.Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.A novel gene delivery system using EGF receptor-mediated endocytosis.In vivo 31P MRS evaluation of ganciclovir toxicity in C6 gliomas stably expressing the herpes simplex thymidine kinase gene.Gene therapy and targeted toxins for glioma
P2860
Q30658073-C00855AA-D417-4BF6-B599-F3C559AAD1BCQ30761595-326F457E-1D83-4C9C-A802-521538CD9F9FQ33582065-A94D6697-33AF-435D-8E3D-F40C0E5DFD15Q33827571-C997B672-190A-4EA5-9462-CAF150545AB6Q34074708-75ED451B-6AEC-4D0D-9A10-9F32E7F5DDC0Q34074791-A1D49FF7-7641-42E6-B008-71B5ADFDBC0EQ34480736-2DD94826-362C-4B05-A6C3-22BCF94E223DQ34616722-181C6E53-1931-4175-9ECA-E7B7E4F92415Q35118933-D78EF53D-399C-4B65-BA8F-6A703EC3E997Q37247954-E68295CC-D799-462A-97DD-BEA98132DBA2Q37740141-8A1512AE-A3B8-48B3-AA35-FC871F477191Q40718975-3E387693-D16B-470B-B4D9-73431FD371EAQ40811121-FC37968A-C4EC-4DDF-85AD-6CAA023AB1D2Q40825648-203AC0EB-15C2-4C87-AEE1-3C63A5FF491FQ40905765-827C63DF-160C-44F4-B28D-A0A174E48C1FQ40933789-FEA93DAF-E5E9-4D5F-B8A1-4063C35847D7Q40957115-7F840E2E-6557-4F0D-B3BD-5FE610BD0799Q41332176-872410EF-2811-4509-BF6C-22733047BE37Q42448457-25D97504-ABC3-4287-9097-E6A97A88C689Q42807227-23BABCA0-8DBA-41ED-B569-2EEE8F1DD9FEQ43883466-FFA40693-3FFF-4A86-8FCB-FD99E4252C36Q45714279-F502F9DA-09CD-47E9-B49C-0B97C9813255Q45747423-26852540-A6F4-4D6D-BCA2-7BFF6F143DC3Q45873823-112ED086-8F2A-4F8C-B625-8CBC1FCEE542Q45882112-A173B041-E8B4-47EC-BB9B-B475CF328663Q57006162-594118AA-705A-4C2E-BE94-6F93FBF5A275
P2860
An experimental model of retrovirus gene therapy for malignant brain tumors.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
An experimental model of retrovirus gene therapy for malignant brain tumors.
@en
type
label
An experimental model of retrovirus gene therapy for malignant brain tumors.
@en
prefLabel
An experimental model of retrovirus gene therapy for malignant brain tumors.
@en
P2093
P1476
An experimental model of retrovirus gene therapy for malignant brain tumors.
@en
P2093
Breakefield XO
Martuza RL
Moolten FL
Takamiya Y
P304
P356
10.3171/JNS.1993.79.1.0104
P407
P577
1993-07-01T00:00:00Z